- Home
- EHTH vs AGEN Comparison
EHTH vs AGEN Comparison
Compare EHTH & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- AGEN
- Stock Information
- Founded
- EHTH 1997
- AGEN 1994
- Country
- EHTH United States
- AGEN United States
- Employees
- EHTH N/A
- AGEN N/A
- Industry
- EHTH Specialty Insurers
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EHTH Finance
- AGEN Health Care
- Exchange
- EHTH Nasdaq
- AGEN Nasdaq
- Market Cap
- EHTH 105.1M
- AGEN 123.6M
- IPO Year
- EHTH 2006
- AGEN 2000
- Fundamental
- Price
- EHTH $5.65
- AGEN $3.98
- Analyst Decision
- EHTH Buy
- AGEN Buy
- Analyst Count
- EHTH 4
- AGEN 2
- Target Price
- EHTH $8.50
- AGEN $14.50
- AVG Volume (30 Days)
- EHTH 400.8K
- AGEN 446.2K
- Earning Date
- EHTH 11-06-2025
- AGEN 11-11-2025
- Dividend Yield
- EHTH N/A
- AGEN N/A
- EPS Growth
- EHTH N/A
- AGEN N/A
- EPS
- EHTH N/A
- AGEN N/A
- Revenue
- EHTH $547,491,000.00
- AGEN $101,706,000.00
- Revenue This Year
- EHTH $4.88
- AGEN $60.49
- Revenue Next Year
- EHTH $3.42
- AGEN N/A
- P/E Ratio
- EHTH N/A
- AGEN N/A
- Revenue Growth
- EHTH 16.19
- AGEN N/A
- 52 Week Low
- EHTH $3.18
- AGEN $1.38
- 52 Week High
- EHTH $11.36
- AGEN $7.34
- Technical
- Relative Strength Index (RSI)
- EHTH 69.00
- AGEN 43.36
- Support Level
- EHTH $5.14
- AGEN $3.97
- Resistance Level
- EHTH $5.89
- AGEN $4.60
- Average True Range (ATR)
- EHTH 0.39
- AGEN 0.24
- MACD
- EHTH 0.06
- AGEN 0.02
- Stochastic Oscillator
- EHTH 90.48
- AGEN 20.26
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).